(Q26746901)
Statements
SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives (English)
0 references
4 June 2016
14 references
13 March 2019
14 March 2019
24 March 2019
31 July 2019
2 October 2019
9 October 2019
17 November 2019
18 November 2019
15 December 2019
26 January 2021
30 January 2021
4 February 2021
19 July 2022
24 August 2022
14 references
13 March 2019
14 March 2019
24 March 2019
31 July 2019
2 October 2019
9 October 2019
17 November 2019
18 November 2019
15 December 2019
26 January 2021
30 January 2021
4 February 2021
19 July 2022
24 August 2022
12
0 references
239-49
0 references
14 references
13 March 2019
14 March 2019
24 March 2019
31 July 2019
2 October 2019
9 October 2019
17 November 2019
18 November 2019
15 December 2019
26 January 2021
30 January 2021
4 February 2021
19 July 2022
24 August 2022
1 reference
1 reference
1 reference